Interview: Chih-Yi Weng – Chairlady & CEO, Botanicure Biotechnology, Taiwan
Chih-Yi Weng, chairlady and CEO of Botanicure Biotechnology, one of Taiwan’s leading biotech companies focused on the development of botanical new drugs as well as topical and personal care products, provides insights into the company’s unique business model and its promising and maturing R&D pipeline, while Botanicure was ranked in 2015 by Deloitte as one of the fastest growing life sciences companies in Asia Pacific. Could you introduce Botanicure Biotechnology to our international readers and document the vision that has been driving its development since the company’s creation, in 2002?Source: https://pharmaboardroom.com/